TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31184539

Group type: EXPERIMENTAL
Intervention: Countermovement Jump (CMJ) with 10% body weight load
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Squat Jump (SJ) with 10% body weight load
Number of subjects: 40

Group type: COMPARATOR
Intervention: Countermovement Jump (CMJ) without additional load
Number of subjects: 40

Group type: COMPARATOR
Intervention: Squat Jump (SJ) without additional load
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Unilateral jumps on each leg with and without an added load
Number of subjects: 40
Study: 28336297

Group type: EXPERIMENTAL
Intervention: Home-based telerehabilitation program (12-week, real-time exercise and education intervention delivered twice weekly via online videoconferencing)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Traditional hospital outpatient-based program (12-week, same duration and frequency as telerehabilitation)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Home-based telerehabilitation program
Number of subjects: 53

Group type: COMPARATOR
Intervention: Traditional hospital outpatient-based program
Number of subjects: 53
Study: 25812548

Group type: EXPERIMENTAL
Intervention: Craniocervical flexion (CCF) exercises
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cervical flexion (CF) exercises
Number of subjects: 60
Study: 24365174

Group type: EXPERIMENTAL
Intervention: Motivational, individual, and locally anchored exercise intervention (four motivational interviews, six months membership to a sport club, global positioning watch)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Standard care (one hour motivational interview, follow-up interview if requested)
Number of subjects: 236
Study: 21367826

Group type: EXPERIMENTAL
Intervention: 3M Unitek, 0·014 inch Nitinol, 0·017 inch × 0·017 inch heat activated Ni‐Ti
Number of subjects: 132

Group type: COMPARATOR
Intervention: GAC international, 0·014 inch Sentalloy, 0·016 × 0·022 inch Bioforce
Number of subjects: 132

Group type: COMPARATOR
Intervention: Ormco corporation, 0·014 inch Damon Copper Ni‐Ti, 0·014 × 0·025 inch Damon Copper Ni‐Ti
Number of subjects: 132
Study: 19284553

Group type: EXPERIMENTAL
Intervention: Combination of 0.5 mEq/Kg magnesium and 2 mg/Kg vitamin B6
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 17313494

Group type: COMPARATOR
Intervention: Intravenous theophylline
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral theophylline
Number of subjects: 40
Study: 16936810

Group type: EXPERIMENTAL
Intervention: 30% iron-saturated bovine lactoferrin (bLf) (100 mg twice a day)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Ferrous sulfate (520 mg once a day)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (pregnant women refusing treatment)
Number of subjects: 300
Study: 14503831

Group type: EXPERIMENTAL
Intervention: RTD fiber posts removal kit (subgroup A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diamond bur and Largo bur (subgroup B)
Number of subjects: 60
Study: 10559098

Group type: EXPERIMENTAL
Intervention: AECC radiographic criterion for ALI-ARDS
Number of subjects: 21
Study: 9122016

Group type: EXPERIMENTAL
Intervention: Dipyridamole echocardiography test
Number of subjects: 97
Study: 1934867

Group type: EXPERIMENTAL
Intervention: Fish oil (5 gm omega-3 fatty acids per day for 30 days)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Naloxone (10 mg intravenous before the cold pressor test)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (for both fish oil and naloxone)
Number of subjects: 26
Study: 7011222

Group type: EXPERIMENTAL
Intervention: Cefoxitin +/‐ amikacin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clindamycin + amikacin
Number of subjects: 100
Study: 31055725

Group type: EXPERIMENTAL
Intervention: Skin staples (29 patients)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Nylon sutures (32 patients)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study: 31161217

Group type: EXPERIMENTAL
Intervention: Red meat diet
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: White meat diet
Number of subjects: 113

Group type: COMPARATOR
Intervention: Nonmeat protein diet
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: High saturated fat intake
Number of subjects: 113

Group type: COMPARATOR
Intervention: Low saturated fat intake
Number of subjects: 113
Study: 27990661

Group type: EXPERIMENTAL
Intervention: Increasing BMI
Number of subjects: 7275

Group type: EXPERIMENTAL
Intervention: Decreased androgen levels
Number of subjects: 7275
Study: 25686538

Group type: EXPERIMENTAL
Intervention: Online pain self-management program
Number of subjects: 228

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 228
Study: 23977198

Group type: EXPERIMENTAL
Intervention: DEP-CAF (5 mg.kg(‐1) of caffeine intake 1 hour before the trial)
Number of subjects: 7

Group type: COMPARATOR
Intervention: DEP-PLA (placebo after CHO availability-lowering exercise)
Number of subjects: 7

Group type: COMPARATOR
Intervention: CON (no previous exercise)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: DEP-CAF
Number of subjects: 7

Group type: COMPARATOR
Intervention: DEP-PLA and CON
Number of subjects: 7
Study: 21410130

Group type: EXPERIMENTAL
Intervention: Electric muscle stimulation and standard physiotherapy for 6 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Physiotherapy only
Number of subjects: 70
Study: 19752272

Group type: EXPERIMENTAL
Intervention: Cephalothin in severely burned patients
Number of subjects: 14

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 14
Study: 17254579

Group type: EXPERIMENTAL
Intervention: Gonadotropin in combination with metformin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 0
Study: 15491275

Group type: EXPERIMENTAL
Intervention: Angry opponent
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Happy opponent
Number of subjects: 3

Group type: COMPARATOR
Intervention: No emotion (control)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Low time pressure
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: High time pressure
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Low power
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: High power
Number of subjects: 3
Study: 11585696

Group type: EXPERIMENTAL
Intervention: Oral formulation with external preparation
Number of subjects: 53

Group type: COMPARATOR
Intervention: Oral formulation alone
Number of subjects: 53
Study: 9141729

Group type: EXPERIMENTAL
Intervention: Group exercise program (12 months)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 187
Study: 7957534

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 100 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Methylprednisolone (MP) 20 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 200 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Methylprednisolone (MP) 40 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 400 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Methylprednisolone (MP) 80 mg
Number of subjects: 18
Study: 3608594

Group type: EXPERIMENTAL
Intervention: Pen method of measuring skin induration
Number of subjects: 135

Group type: COMPARATOR
Intervention: Palpation method of measuring skin induration
Number of subjects: 135
Study: 31005823

Group type: EXPERIMENTAL
Intervention: 24-epibrassinolide (10-8 M)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study: 28099755

Group type: EXPERIMENTAL
Intervention: Insulin analogue (insulin detemir/insulin aspart)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Human insulin (human NPH insulin/human regular insulin)
Number of subjects: 72
Study: 25956891

Group type: EXPERIMENTAL
Intervention: Valacyclovir (VACV) 2 g thrice daily for 90 days (n = 40)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo tablets for 90 days (n = 47)
Number of subjects: 87
Study: 23254903

Group type: EXPERIMENTAL
Intervention: Calcium carbonate (1500 mg/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 21281410

Group type: EXPERIMENTAL
Intervention: Online LSVT®
Number of subjects: 34

Group type: COMPARATOR
Intervention: Face-to-face LSVT®
Number of subjects: 34
Study: 19195731

Group type: EXPERIMENTAL
Intervention: Field matching techniques (including half beam blocking and machine rotations)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Geometric alignment techniques
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Film dosimetry with a breast-shaped phantom
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gap techniques
Number of subjects: 0
Study: 16703969

Group type: EXPERIMENTAL
Intervention: Therapeutic thoracic medial branch blocks
Number of subjects: 55
Study: 15867730

Group type: EXPERIMENTAL
Intervention: Indwelling urethral catheters removed at midnight
Number of subjects: 8

Group type: COMPARATOR
Intervention: Indwelling urethral catheters removed in the morning
Number of subjects: 8
Study: 12134989

Group type: EXPERIMENTAL
Intervention: Multifocal IOL
Number of subjects: 40

Group type: COMPARATOR
Intervention: Monofocal IOL
Number of subjects: 40
Study: 9607277

Group type: EXPERIMENTAL
Intervention: Dual energy X-ray absorptiometry for evaluating bone density in patients with proximal femur fractures.
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Threshold values for ZYA established for different areas of the proximal femur: femoral neck -1.3 SD, Ward's triangle -1.5 SD, trochanteric area -0.4 SD.
Number of subjects: 369
Study: 7706096

Group type: EXPERIMENTAL
Intervention: 6 hours of bedrest after sheath removal
Number of subjects: 85

Group type: COMPARATOR
Intervention: 8 hours of bedrest after sheath removal
Number of subjects: 85
Study: 2705602

Group type: EXPERIMENTAL
Intervention: Free care
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cost-sharing plans
Number of subjects: 100
Study: 335789

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ) 200 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ) 400 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ) 600 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chlorpromazine (CPZ)
Number of subjects: 0
Study: 31441769

Group type: EXPERIMENTAL
Intervention: Home gardens intervention (details on dosage and duration not available)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Baseline measures collected before the intervention
Number of subjects: 176
Study: 28553836

Group type: EXPERIMENTAL
Intervention: Riluzole (100 mg/day)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 26363409

Group type: EXPERIMENTAL
Intervention: Plasmodium falciparum sporozoites (CPS) immunization
Number of subjects: 15
Study: 23474315

Group type: EXPERIMENTAL
Intervention: BCG
Number of subjects: 345
Study: 20870464

Group type: EXPERIMENTAL
Intervention: Conventional TENS
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Acupuncture-like TENS
Number of subjects: 23
Study: 19786417

Group type: EXPERIMENTAL
Intervention: Expert tutor group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Non-expert tutor group
Number of subjects: 30
Study: 17303257

Group type: EXPERIMENTAL
Intervention: Early decompression (transnasal trans‐sphenoidal optic nerve decompression)
Number of subjects: 31
Study: 15025850

Group type: EXPERIMENTAL
Intervention: Almitrine + raubasine
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 10706231

Group type: EXPERIMENTAL
Intervention: Daily vitamin‐mineral supplementation at 50% of the U.S. recommended daily allowance (RDA) for 4 months
Number of subjects: 468

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 468
Study: 8951686

Group type: EXPERIMENTAL
Intervention: Cysteamine drops (0.5% and 1.0%) administered preoperatively every half hour for two, four, six or eight hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 1348805

Group type: EXPERIMENTAL
Intervention: Injection treatment (1‐2 ml of 1 in 10,000 adrenaline injected at four to six sites around the ulcer)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Standard treatment alone (control)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Injection treatment
Number of subjects: 93
Study: 3908121

Group type: EXPERIMENTAL
Intervention: Nifedipine 20-40 mg twice daily
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Labetalol 200-400 mg twice daily
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Nifedipine and Labetalol in combination
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Labetalol alone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Nifedipine alone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combination therapy (Nifedipine and Labetalol)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Labetalol alone and in combination with Nifedipine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Nifedipine and Labetalol
Number of subjects: 25
Study: 30704452

Group type: EXPERIMENTAL
Intervention: Students who wrote questions for General Pathology (Immunopathology)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Students who wrote questions for Pathophysiology (Respiratory system)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Male students writing good questions in Pathophysiology
Number of subjects: 184
Study: 28928100

Group type: EXPERIMENTAL
Intervention: Propofol-alfentanil (Group A)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Propofol-fentanyl (Group F)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Propofol only (Group P)
Number of subjects: 150
Study: 25990225

Group type: EXPERIMENTAL
Intervention: Towards Flourishing Mental Health Promotion Strategy
Number of subjects: 13

Group type: COMPARATOR
Intervention: Existing public health home visiting program
Number of subjects: 13
Study: 23848077

Group type: EXPERIMENTAL
Intervention: Novasource Diabet Smartflex
Number of subjects: 15
Study: 22143221

Group type: EXPERIMENTAL
Intervention: Web-based health education intervention (12 weeks duration)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 49
Study: 19853687

Group type: EXPERIMENTAL
Intervention: Combination of oral anticoagulation therapy and clopidogrel 75 mg/d
Number of subjects: 496

Group type: COMPARATOR
Intervention: Triple therapy (clopidogrel + oral anticoagulants + aspirin)
Number of subjects: 496
Study: 16500914

Group type: EXPERIMENTAL
Intervention: 5FU/LV/oxaliplatin
Number of subjects: 302

Group type: COMPARATOR
Intervention: 5FU/LV
Number of subjects: 302
Study: 15601473

Group type: EXPERIMENTAL
Intervention: Home visits by experienced home nurses (at least 8 visits over 18 months)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Home visits by experienced home nurses
Number of subjects: 330
Study: 11482539

Group type: EXPERIMENTAL
Intervention: Physical therapy
Number of subjects: 135

Group type: COMPARATOR
Intervention: Prescription of multivitamins
Number of subjects: 135
Study: 9284853

Group type: EXPERIMENTAL
Intervention: Recombinant human interleukin-10 (1.0, 2.5, 5.0, 10, 25, or 50 micrograms/kg)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 8227938

Group type: EXPERIMENTAL
Intervention: Eyedrops to eyes that were closed
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Eyedrops to eyes that were open
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Spray to eyes that were closed
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Spray to eyes that were open
Number of subjects: 38
Study: 3468302

Group type: EXPERIMENTAL
Intervention: 7 S IgG
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3291634

Group type: EXPERIMENTAL
Intervention: Impregnated sheets with benzyl benzoate
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo sheets (inactive sheets)
Number of subjects: 36
Study: 31928523

Group type: EXPERIMENTAL
Intervention: Hypnosis (24 sessions over 6 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard medical care (Control group)
Number of subjects: 40
Study: 29463233

Group type: EXPERIMENTAL
Intervention: Oral cholera vaccine (OCV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27852348

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy plus (CBT+)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Guided Self-Help Cognitive Behavior Therapy (cGSH)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: DBT
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: CBT
Number of subjects: 109
Study: 26365791

Group type: EXPERIMENTAL
Intervention: IUD insertion with baseline dysmenorrhea scores
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: IUD insertion with insertion pain
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: IUD insertion
Number of subjects: 199
Study: 23201301

Group type: EXPERIMENTAL
Intervention: Cooking intervention with professional chefs
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4
Study: 21973111

Group type: EXPERIMENTAL
Intervention: Enhanced treatment group
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Focus group participation
Number of subjects: 33
Study: 18514485

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0
Study: 16556244

Group type: EXPERIMENTAL
Intervention: Headache response at 0.5 hours
Number of subjects: 0
Study: 12930465

Group type: EXPERIMENTAL
Intervention: Nurse‐Family Partnership pilot study home visitation program
Number of subjects: 225

Group type: COMPARATOR
Intervention: Traditional Public Health Field Nursing (PHFN) services
Number of subjects: 225
Study: 10955773

Group type: EXPERIMENTAL
Intervention: 4‐HPR (200 mg once daily)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: 4‐HPR
Number of subjects: 82
Study: 8694306

Group type: EXPERIMENTAL
Intervention: Remifentanil small dose (0.5 micrograms.kg‐1.min‐1)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Remifentanil large dose (1 microgram.kg‐1.min‐1)
Number of subjects: 161
Study: 1349488

Group type: EXPERIMENTAL
Intervention: terfenadine 60 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 3934932

Group type: EXPERIMENTAL
Intervention: iohexol
Number of subjects: 60

Group type: COMPARATOR
Intervention: metrizamide
Number of subjects: 60
Study: 31947735

Group type: EXPERIMENTAL
Intervention: PLAYTOD program
Number of subjects: 0
Study: 29948199

Group type: EXPERIMENTAL
Intervention: Voluntary contractions combined with hypopressive exercises (HYPO)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Biofeedback exercises combined with transvaginal electrical stimulations (ELEC)
Number of subjects: 24
Study: 27026424

Group type: EXPERIMENTAL
Intervention: Bioimpedance spectroscopy (BIS) by Xitron 4200
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 8-electrode multifrequency impedance (MFBIA) by Tanita MC180MA
Number of subjects: 70

Group type: COMPARATOR
Intervention: Dual energy X-ray absorptiometry (DXA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Doubly labeled water (DLW)
Number of subjects: 70
Study: 25281929

Group type: EXPERIMENTAL
Intervention: Placebo (lidocaine)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Nocebo (capsaicin)
Number of subjects: 18
Study: 21664014

Group type: EXPERIMENTAL
Intervention: VR/Haptics IV Simulator (IV sim)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Conventional arm model (IV arm)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Both IV arm and IV sim
Number of subjects: 114
Study: 21095484

Group type: EXPERIMENTAL
Intervention: Generic atorvastatin 20 mg/d
Number of subjects: 244

Group type: COMPARATOR
Intervention: Branded atorvastatin 20 mg/d
Number of subjects: 244
Study: 18664782

Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 32

Group type: COMPARATOR
Intervention: Enoximone
Number of subjects: 32
Study: 15997937

Group type: EXPERIMENTAL
Intervention: Periodontal ligament injection with the Wand
Number of subjects: 25

Group type: COMPARATOR
Intervention: Traditional syringe injection
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Preference of technique
Number of subjects: 25
Study: 11797017

Group type: EXPERIMENTAL
Intervention: Urinary dipsticks (Multistix 8‐SG) analyzed by the reflectance spectrophotometric method (Clinitek 50)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Quantitative urine culture (QUC)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Urinary dipsticks (UD) strategy
Number of subjects: 144
Study: 9549398

Group type: EXPERIMENTAL
Intervention: Rest/postnitroglycerin (0.4 mg sublingually) technetium‐99m tetrofosmin SPET
Number of subjects: 28

Group type: COMPARATOR
Intervention: Thallium‐201 rest/redistribution SPET
Number of subjects: 28

Group type: COMPARATOR
Intervention: Thallium‐201 rest/reinjection SPET
Number of subjects: 28
Study: 8019029

Group type: EXPERIMENTAL
Intervention: University of Wisconsin (UW) solution
Number of subjects: 149

Group type: COMPARATOR
Intervention: Hypothermic continuous pulsatile perfusion
Number of subjects: 149
Study: 2783734

Group type: EXPERIMENTAL
Intervention: Vitamin D2 supplementation (400 IU/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (unsupplemented human milk)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Standard infant formula
Number of subjects: 46